DNA

European collaboration demonstrates the value of targeted tumor analysis

Roche’s PATHWAY HER2 (4B5) test is the only test approved to identify all levels of HER2 expression

MIT researchers have dramatically lowered the error rate of prime editing, a technique that holds potential for treating many genetic disorders

Joint consensus report includes organizational representation from AMP, ASCO, ACCC, and CAP

Reverse transcription has fundamentally reshaped molecular biology by enabling the flow of genetic information from RNA back to DNA

Join Today’s Clinical Lab with experts from Targeted Genomics and DNA Genotek for an in-depth discussion on the role of Genetic Health Risk Tests (GHR) in advancing personalized healthcare, and how integrating sample collection devices validated for their analytical performance can enhance the reliability and accessibility of GHRs

Cost, time, and labor considerations still make the Sanger method a better choice amidst new sequencing technologies

Researchers have found that a test to detect circulating tumor DNA can predict lung cancer outcome

This bisulfite-free method of methylation detection provides a faster, more streamlined workflow that enables highly sensitive analysis

Study is the first to identify discrete genetic mutations associated with smoking, to establish a dose-response relationship between smoking and genetic mutations and to show that continuing to smoke leads to more mutations and worse MDS